XBI:NYE-SPDR® S&P Biotech ETF (USD)

ETF | Health |

Last Closing

USD 98.43

Change

0.00 (0.00)%

Market Cap

N/A

Volume

6.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing XBI

MATH Metalpha Technology Holdi.. 0.00 % 1.35 %

N/A

USD 0.04B
INAV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -63.25% 19% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -63.25% 19% F 6% D-
Trailing 12 Months  
Capital Gain -55.07% 24% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -55.07% 24% F 7% C-
Trailing 5 Years  
Capital Gain -56.97% 19% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.97% 19% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain 2.38% N/A N/A 47% F
Dividend Return 2.46% N/A N/A 37% F
Total Return 0.08% N/A N/A 3% F
Risk Return Profile  
Volatility (Standard Deviation) 32.87% N/A N/A 30% F
Risk Adjusted Return 7.50% N/A N/A 29% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike